US equities
|
MU
$931.24
▲+1.87%
NVDA
$217.23
▼-1.84%
SNDK
$1,394.83
▼-0.61%
AMD
$562.23
▼-1.50%
SPCX
$148.62
▼-2.33%
INTC
$95.37
▼-2.80%
AAPL
$342.00
▼-0.28%
MSFT
$539.44
▲+1.08%
MU
$931.24
▲+1.87%
NVDA
$217.23
▼-1.84%
SNDK
$1,394.83
▼-0.61%
AMD
$562.23
▼-1.50%
SPCX
$148.62
▼-2.33%
INTC
$95.37
▼-2.80%
AAPL
$342.00
▼-0.28%
MSFT
$539.44
▲+1.08%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Ventripoint Diagnstcs Ltd
(OP:
VPTDF
)
0.0585
-0.0019 (-3.15%)
Delayed Quote
Updated: 3:05 PM EDT, Oct 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ventripoint Diagnstcs Ltd
Ventripoint Expands Subscription Access for FDA-Cleared AI Cardiac Imaging
August 12, 2026
Commercial initiative aims to make VMS+ easier for hospitals to evaluate and adopt
From
Ventripoint Diagnostics Ltd
Via
GlobeNewswire
A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech
May 13, 2026
Issued on behalf of VentriPoint Diagnostics Ltd.
From
USA News Group
Via
GlobeNewswire
The Infrastructure Play Hiding in Plain Sight Across Cardiac Care
April 16, 2026
Issued on behalf of VentriPoint Diagnostics Ltd.
From
Equity Insider
Via
GlobeNewswire
The Quiet Shift Replacing Million-Dollar Heart Scanners With Software
April 16, 2026
Issued on behalf of VentriPoint Diagnostics Ltd.
From
USA News Group
Via
GlobeNewswire
THE SIGNAL ARCHITECTURE: 5 Stocks Calibrating the 2026 Infrastructure Cycle
February 24, 2026
Issued on behalf of Quantum Secure Encryption Corp.
From
USA News Group
Via
GlobeNewswire
THE SOVEREIGNTY DOCTRINE: 5 Assets Locking Down the 2026 Survival Cycle
February 05, 2026
Issued on behalf of Quantum Secure Encryption Corp.
From
USA News Group
Via
GlobeNewswire
AI Diagnostics: The End of the High-Cost Imaging Era
January 16, 2026
Issued on behalf of VentriPoint Diagnostics Ltd.
From
Equity Insider
Via
GlobeNewswire
THE SCARCITY DOCTRINE: 5 Assets Securing the 2026 Material Cycle
January 16, 2026
Issued on behalf of Ventripoint Diagnostics Ltd.
From
Equity Insider
Via
GlobeNewswire
THE FOUNDATION TRADE: 5 Assets Anchoring the Next Industrial Cycle
December 17, 2025
Issued on behalf of GoldHaven Resources Corp.
From
USA News Group
Via
GlobeNewswire
THE VISIBILITY INDEX: 5 Companies Solving the Invisible Crisis
December 15, 2025
Issued on behalf of Ventripoint Diagnostics Ltd.
From
USA News Group
Via
GlobeNewswire
Healthcare AI Exits Pilot Phase, Enters Production Deployment
December 12, 2025
Issued on behalf of VentriPoint Diagnostics Ltd.
From
Equity Insider
Via
GlobeNewswire
From Hype to P&L: Hospitals Now Buying AI That Pays
December 08, 2025
ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD.
From
USA News Group
Via
GlobeNewswire
THE EFFICIENCY PARADOX: 5 Market Anomalies Trading Below Reality
December 06, 2025
Issued on behalf of Oncolytics Biotech Inc.
From
USA News Group
Via
GlobeNewswire
UPDATE -- The Efficiency Gap: Five Assets Where Price Has Yet To Reflect Reality
December 03, 2025
Issued on behalf of Oncolytics Biotech Inc.
From
USA News Group
Via
GlobeNewswire
The Efficiency Gap: Five Assets Where Price Has Yet To Reflect Reality
December 03, 2025
Issued on behalf of Oncolytics Biotech Inc.
From
USA News Group
Via
GlobeNewswire
Ventripoint's Next Generation, AI-powered Heart-Scanning Technology Submitted for EU Medical Device Regulation Certification
October 11, 2024
Toronto, Ontario - TheNewswire - (October 11, 2024) - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTCQB:VPTDF) is pleased to announce that it has submitted its next...
Via
TheNewswire.com
Topics
Artificial Intelligence
Ventripoint Welcomes Evelina London Children's Hospital as Newest VMS+ User
August 22, 2023
Toronto, Ontario – TheNewswire – August 22, 2023 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT) (OTC:VPTDF) is pleased to announce that Evelina London Children’s Hospital...
Via
TheNewswire.com
Ventripoint to Exhibit at the American College of Cardiology 71st Annual Scientific Session and Expo and Correction to North Equities Corp Grant of Stock Options
April 01, 2022
Toronto, Ontario – TheNewswire – April 1, 2022 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is pleased to announce that it will be exhibiting at the 71st...
Via
TheNewswire.com
Ventripoint Announces Patent Application for Improved Heart Analysis
August 09, 2021
Toronto, Ontario – TheNewswire – August 09, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) has filed an international patent application under the Patent...
Via
TheNewswire.com
Topics
Artificial Intelligence
Intellectual Property
Ventripoint Engages Digital257 for Social Media and Investor Relations Services
July 05, 2021
Toronto, Ontario – TheNewswire – July 5, 2021 - Ventripoint Diagnostics Ltd. (" Ventripoint " or the " Company "), (TSXV:VPT ) ; (OTC:VPTDF) is pleased to announce that it has engaged Digital257...
Via
TheNewswire.com
Topics
Artificial Intelligence
Ventripoint Issues Option Grants to Consultants and a Director of the Corporation
July 02, 2021
Toronto, Ontario – TheNewswire – July 2, 2021 - Ventripoint Diagnostics Ltd. (“ Ventripoint ” or the “ Corporation ”) (TSXV:VPT) (OTC:VPTDF) announces that on July 1, 2021 the Board of Directors...
Via
TheNewswire.com
Topics
Artificial Intelligence
Ventripoint Announces Sponsorship for the 54th Annual Meeting of the Association of European Paediatric and Congenital Cardiology
May 21, 2021
Ventripoint Also Provides a Financial Update
Via
TheNewswire.com
Topics
Artificial Intelligence
Ventripoint update on its Financial Status and on Warrant and Option Exercises
May 06, 2021
Toronto, Ontario – TheNewswire – May 6, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is pleased to provide this update on its financial status and the...
Via
TheNewswire.com
Topics
Artificial Intelligence
Ventripoint Receives Government Funding to Advance Development of Next Generation of VMS+
May 04, 2021
Toronto, Ontario – TheNewswire – May 4, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is excited to announce that it is receiving advisory services and...
Via
TheNewswire.com
Topics
Artificial Intelligence
Ventripoint Collaborates with GE Healthcare to Bring More Functionality to its Cardiac Ultrasound Devices
April 27, 2021
Toronto, Ontario - The Newswire - April 27, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT) (OTC:VPTDF) announces the Company has entered into a collaboration with GE...
Via
TheNewswire.com
Topics
Artificial Intelligence
Ventripoint Attends 23rd Annual Canadian Echo Weekend and Grants Stock Options
April 20, 2021
Toronto, Ontario – TheNewswire – April 20, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) attended the 23rd Annual Canadian Echo Weekend – 2021 Digital...
Via
TheNewswire.com
Topics
Artificial Intelligence
Ventripoint Extends Patent Portfolio with Foundational U.S. Provisional Patent Filing of Heart Motion Tracking Technology
April 19, 2021
Toronto, Ontario - The Newswire - April 19, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT) (OTC:VPTDF) has filed a U.S. provisional patent application for its novel...
Via
TheNewswire.com
Topics
Artificial Intelligence
Intellectual Property
Ventripoint Announces Sponsorship for the 2021 Canadian Society of Echocardiography Weekend Conference
April 15, 2021
Toronto, Ontario – TheNewswire – April 15, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is pleased to announce its sponsorship of the 2021 Canadian...
Via
TheNewswire.com
Topics
Artificial Intelligence
Ventripoint Diagnostics Begins Publication of Case Studies Showing Meritorious Use of the VMS Heart Analysis System
April 13, 2021
Toronto, Ontario – TheNewswire – April 13, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) has published its first case study of the meritorious use of the...
Via
TheNewswire.com
Topics
Artificial Intelligence
